141 related articles for article (PubMed ID: 7914453)
21. Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.
Socinski MA
Oncologist; 1999; 4(5):408-16. PubMed ID: 10551557
[TBL] [Abstract][Full Text] [Related]
22. Taxol: a history of pharmaceutical development and current pharmaceutical concerns.
Adams JD; Flora KP; Goldspiel BR; Wilson JW; Arbuck SG; Finley R
J Natl Cancer Inst Monogr; 1993; (15):141-7. PubMed ID: 7912520
[TBL] [Abstract][Full Text] [Related]
23. Tour de paclitaxel: biocatalysis for semisynthesis.
Patel RN
Annu Rev Microbiol; 1998; 52():361-95. PubMed ID: 9891802
[TBL] [Abstract][Full Text] [Related]
24. Single-agent paclitaxel in the treatment of breast cancer: phase I and II development.
Seidman AD
Semin Oncol; 1999 Jun; 26(3 Suppl 8):14-20. PubMed ID: 10403469
[TBL] [Abstract][Full Text] [Related]
25. Nursing management of the patient receiving Taxol therapy.
Noone MH; McCabe MS; Denicoff AM; Lepore JM
J Natl Cancer Inst Monogr; 1993; (15):149-54. PubMed ID: 7912521
[TBL] [Abstract][Full Text] [Related]
26. [A phase II clinical study of China-made paclitaxel in the treatment of cancer patients].
Wu H; Guan Z; Lin T
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):148-52. PubMed ID: 10920970
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Hecker D; Hanske M
Semin Oncol; 1996 Dec; 23(6 Suppl 16):47-50. PubMed ID: 9007121
[TBL] [Abstract][Full Text] [Related]
28. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
Chang AY; Boros L; Asbury R; Hui L; Rubins J
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
[TBL] [Abstract][Full Text] [Related]
29. Taxol commercial supply strategy.
DeFuria MD; Horovitz Z
J Natl Cancer Inst Monogr; 1993; (15):195-8. PubMed ID: 7912526
[TBL] [Abstract][Full Text] [Related]
30. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.
Johnson KR; Young KK; Fan W
Clin Cancer Res; 1999 Sep; 5(9):2559-65. PubMed ID: 10499633
[TBL] [Abstract][Full Text] [Related]
31. Total synthesis of taxol.
Nicolaou KC; Yang Z; Liu JJ; Ueno H; Nantermet PG; Guy RK; Claiborne CF; Renaud J; Couladouros EA; Paulvannan K
Nature; 1994 Feb; 367(6464):630-4. PubMed ID: 7906395
[TBL] [Abstract][Full Text] [Related]
32. Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.
Luck HJ; Thomssen C; duBois A; Lisboa BW; Untch M; Kuhnle H; Konecny G; Janicke F; Meerpohl HG; Lindner C; Hecker D; Diergarten K
Semin Oncol; 1996 Feb; 23(1 Suppl 1):33-6. PubMed ID: 8629034
[TBL] [Abstract][Full Text] [Related]
33. Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer.
Dombernowsky P; Gehl J; Boesgaard M; Jensen TP; Jensen BV
Semin Oncol; 1996 Feb; 23(1 Suppl 1):13-8. PubMed ID: 8629030
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
AbouEl Hassan MA; Braam SR; Kruyt FA
Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
36. Taxol plus radiation for head and neck cancer.
Rosenthal DI; Carbone DP
J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
[TBL] [Abstract][Full Text] [Related]
37. Biological activity and chemistry of taxoids from the Japanese yew, Taxus cuspidata.
Shigemori H; Kobayashi J
J Nat Prod; 2004 Feb; 67(2):245-56. PubMed ID: 14987066
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel (taxol).
Kohler DR; Goldspiel BR
Pharmacotherapy; 1994; 14(1):3-34. PubMed ID: 7909150
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel pharmacology and other tumor types.
Rowinsky EK
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]